Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.41 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.41 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.41 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11119110 | 0.77 | ATM (0.58) | ATML3MBTL1LMNACYP2D6CYP2C9 | |
| SCHEMBL5690338 | 0.77 | ATM (0.58) | ATML3MBTL1LMNACYP2D6CYP2C9 | |
| SCHEMBL2246434 | 0.77 | ATM (0.58) | ATML3MBTL1LMNACYP2D6CYP2C9 | |
| SCHEMBL3936634 | 0.76 | AKR1C3 (0.51) | L3MBTL1CYP4F2CYP4A11LMNACYP2D6 | |
| SCHEMBL27652140 | 0.76 | MAPT (0.58) | ATML3MBTL1LMNAMAPK1 | |
| SCHEMBL1356271 | 0.75 | AKR1C3 (0.52) | CYP4F2CYP4A11LMNAMAPK1 | |
| SCHEMBL11370912 | 0.74 | ATM (0.41) | ATMNR1H2NR1H3CYP4F2CYP4A11 | |
| SCHEMBL14166147 | 0.74 | L3MBTL1 (0.42) | ATML3MBTL1ACHELMNACYP2D6 | |
| SCHEMBL14166148 | 0.74 | L3MBTL1 (0.42) | ATML3MBTL1ACHELMNACYP2D6 | |
| SCHEMBL25567354 | 0.73 | LMNA (0.49) | ATML3MBTL1LMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10974232-B2 | Catalyst, method for forming amide bond, and method for producing amide compound | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 2021-04-13 | — | — | US | disclosed |
| US-20200206724-A1 | Catalyst, Method for Forming Amide Bond, and Method for Producing Amide Compound | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 2020-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200206724-A1 | Catalyst, Method for Forming Amide Bond, and Method for Producing Amide Compound | ASNS, NAAA, PYM1 | ATM 1295/4885L3MBTL1 3221/4885NR1H2 916/4885 |
| US-10974232-B2 | Catalyst, method for forming amide bond, and method for producing amide compound | ASNS, NAAA, PYM1 | ATM 1295/4885L3MBTL1 3221/4885NR1H2 916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.